StockData
TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (TXMD) stock

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.81−0.10 (-5.24%)

Close on Nov 18, 2026Market cap $20.95MP/E –Yield –

TherapeuticsMD shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

TherapeuticsMD's shares outstanding was 12M at Jun 30, 2026. For fiscal 2025 it was 12M, up 0.3% from the year before. Over ten years it grew 12.8% a year on average. The highest annual figure on record is 12M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202512M+0.3%
FY2024Dec 31, 202412M+110349.2%
FY2023Dec 31, 20230M-99.9%
FY2022Dec 31, 20229M+17.7%
FY2021Dec 31, 20218M+44.4%
FY2020Dec 31, 20206M+11.9%
FY2019Dec 31, 20195M+9.5%
FY2018Dec 31, 20185M+9.5%
FY2017Dec 31, 20174M+4.8%
FY2016Dec 31, 20164M+13.2%
FY2015Dec 31, 20153M+15.7%
FY2014Dec 31, 20143M+17.4%
FY2013Dec 31, 20133M+39.2%
FY2012Dec 31, 20122M+46.6%
FY2011Dec 31, 20111M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202612M+0.6%
Q1 FY2026Mar 31, 20260M+0.8%
Q4 FY2025Dec 31, 202512M+0.4%
Q3 FY2025Sep 30, 202512M+0.4%
Q2 FY2025Jun 30, 202512M+0.4%
Q1 FY2025Mar 31, 20250M-99.9%
Q4 FY2024Dec 31, 202412M+7.8%
Q3 FY2024Sep 30, 202412M+12.8%
Q2 FY2024Jun 30, 202412M+18.2%
Q1 FY2024Mar 31, 202412M+6.5%
Q3 FY2023Sep 30, 202311M+15.5%
Q2 FY2023Jun 30, 202310M+16.8%
Q1 FY2023Mar 31, 202310M+13.2%
Q4 FY2022Dec 31, 202211M+26.6%
Q3 FY2022Sep 30, 20229M+9.7%
Q2 FY2022Jun 30, 20229M+11.0%
Q1 FY2022Mar 31, 20229M+24.0%
Q4 FY2021Dec 31, 20219M+49.2%
Q3 FY2021Sep 30, 20218M+54.9%
Q2 FY2021Jun 30, 20218M+44.9%
Q1 FY2021Mar 31, 20217M+27.9%
Q4 FY2020Dec 31, 20206M+9.5%
Q3 FY2020Sep 30, 20205M+13.0%
Q2 FY2020Jun 30, 20205M+12.7%
Q1 FY2020Mar 31, 20205M+12.6%
Q4 FY2019Dec 31, 20195M+9.7%
Q3 FY2019Sep 30, 20195M+5.8%
Q2 FY2019Jun 30, 20195M+11.3%
Q1 FY2019Mar 31, 20195M+11.3%
Q4 FY2018Dec 31, 20185M+12.5%
Q3 FY2018Sep 30, 20185M+9.7%
Q2 FY2018Jun 30, 20184M+6.5%
Q1 FY2018Mar 31, 20184M+9.5%
Q4 FY2017Dec 31, 20174M+7.9%
Q3 FY2017Sep 30, 20174M+5.8%
Q2 FY2017Jun 30, 20174M–
Q1 FY2017Mar 31, 20174M–
Q4 FY2016Dec 31, 20164M–
Q3 FY2016Sep 30, 20164M–

More TherapeuticsMD figures

See a number that looks wrong?